Loading…

Cognitive Function in Patients With Chronic Granulomatous Disease: A Preliminary Report

Chronic granulomatous disease is an inherited immunodeficiency in which phagocytes fail to generate superoxide and its metabolites, resulting in severe recurrent infections and frequent hospitalizations. Chronic illness and frequent hospitalizations can affect growth and development as well as socia...

Full description

Saved in:
Bibliographic Details
Published in:Psychosomatics (Washington, D.C.) D.C.), 2004-05, Vol.45 (3), p.230-234
Main Authors: Pao, Maryland, Wiggs, Edythe A., Anastacio, Melissa M., Hyun, Jenny, DeCarlo, Ellen S., Miller, Judi T., Anderson, Victoria L., Malech, Harry L., Gallin, John I., Holland, Steven M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic granulomatous disease is an inherited immunodeficiency in which phagocytes fail to generate superoxide and its metabolites, resulting in severe recurrent infections and frequent hospitalizations. Chronic illness and frequent hospitalizations can affect growth and development as well as social and educational opportunities. Since no data have been reported on cognitive functioning in patients with this illness, the authors sought to examine cognitive function in a group of patients with chronic granulomatous disease. A retrospective chart review of 26 patients seen and followed at the National Institutes of Health who had received cognitive testing at the request of parent or staff was performed. Demographic information including medical, psychiatric, and developmental histories was gathered. Six patients (23%) were found to have an IQ of 70 or below, indicative of cognitive deficits, and all of those patients had defects in the membrane-linked cytochrome b558. The prevalence of cognitive deficits in this selected population of chronic granulomatous disease patients was high. The determination of the true distribution of cognitive functioning in the general chronic granulomatous disease population is important, since cognitive deficits have implications for educational planning and potential therapies such as transplantation and gene therapy in children.
ISSN:0033-3182
1545-7206
DOI:10.1176/appi.psy.45.3.230